Tamiolakis D, Venizelos J, Papadopoulos N, Lambropoulou M, Papadopoulos E, Simopoulos C
Department of Cytology, General Hospital of Alexandroupolis, Greece.
Chirurgia (Bucur). 2005 Sep-Oct;100(5):451-6.
Prognosis of colonic carcinoma is poor. The two most important factors having the greatest effect on survival are pathologic stage of disease and histologic grade of the tumor. Our study points towards the value of HLA-DR antigen in the prognosis of colonic carcinoma. We studied 31 cases of normal colonic mucosa, 12 cases of tubulo-villous adenoma, and 39 cases of invasive carcinoma for the detection of HLA-DR monoclonal antigen. Yet, we investigated the association of HLA-DR and DQ genes and adenoma and carcinoma by PCR. We also studied the T helper (TH) marker (CD4) in the lamina propria of the relevant cases, given that the dependence of immune responsiveness on the class II antigens reflects the central role of these molecules in presenting antigen to TH cells. HLA-DR was expressed in 20 of 31 normal colonic mucosa (64.5%), 4 of 12 adenomas (33.3%), and in 10 of 39 invasive carcinomas (25.6%). No significant correlation between HLA-DR and DQ genes and adenoma or cancer of the colon was found. CD4 was expressed in 9 of 31 normal colonic mucosa (29%), 5 of 12 adenomas (42%), and in 26 of 39 invasive carcinomas (67%). The results showed decreased expression of HLA-DR and increased expression of CD4 as the lesion progressed to malignancy. HLA-DR and DQ genes do not contribute to a susceptibility to adenoma or carcinoma. The immune attract mechanism by low HLA-DR signaling seems to be of minor importance in the malignant and metastatic potential of the colonic carcinoma.
结肠癌的预后较差。对生存影响最大的两个最重要因素是疾病的病理分期和肿瘤的组织学分级。我们的研究表明了HLA - DR抗原在结肠癌预后中的价值。我们检测了31例正常结肠黏膜、12例管状绒毛状腺瘤和39例浸润性癌中的HLA - DR单克隆抗原。此外,我们通过聚合酶链反应(PCR)研究了HLA - DR和DQ基因与腺瘤及癌之间的关联。鉴于免疫反应性对II类抗原的依赖性反映了这些分子在将抗原呈递给辅助性T细胞(TH细胞)中的核心作用,我们还研究了相关病例固有层中的TH标志物(CD4)。HLA - DR在31例正常结肠黏膜中的20例(64.5%)、12例腺瘤中的4例(33.3%)以及39例浸润性癌中的10例(25.6%)中表达。未发现HLA - DR和DQ基因与结肠腺瘤或癌之间存在显著相关性。CD4在31例正常结肠黏膜中的9例(29%)、12例腺瘤中的5例(42%)以及39例浸润性癌中的26例(67%)中表达。结果显示,随着病变进展为恶性,HLA - DR表达降低,CD4表达增加。HLA - DR和DQ基因对腺瘤或癌的易感性没有影响。低HLA - DR信号的免疫吸引机制在结肠癌的恶性和转移潜能中似乎不太重要。